Annual Drug Patent Expirations for DYANAVEL+XR
Dyanavel Xr is a drug marketed by Tris Pharma Inc and is included in two NDAs. It is available from two suppliers. There are eight patents protecting this drug.
DYANAVEL XR drug price trends.
Drug patent litigation for DYANAVEL XR.
This drug has nineteen patent family members in fourteen countries.
The generic ingredient in DYANAVEL XR is amphetamine; amphetamine aspartate/dextroamphetamine sulfate. Two suppliers are listed for this compound. Additional details are available on the amphetamine; amphetamine aspartate/dextroamphetamine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
